Study Stopped
PI changed institutions and was no longer able to continue project.
Initial Intervention Efficacy for an Online PTSD Intervention for Pregnant Women
1 other identifier
interventional
5
1 country
1
Brief Summary
The current study aims to test a brief computer-assisted intervention (psychoeducation + skills) for pregnant women with elevated PTSD symptoms. In this open trial pilot feasibility study, 20 pregnant women in their first trimester will be invited to participate in the study if they endorse elevated PTSD symptoms. Oxytocin and cortisol will be measured at baseline, one month post-intervention, three months post-intervention, and post-delivery to inform the relationship between these hormones, PTSD symptoms, and peripartum/postpartum outcomes. In addition to receiving the psychoeducation + skills intervention during their first trimester, women will be offered a "booster session" intervention following delivery to enhance utilization of skills during a critical period for maternal mental and physical health outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 3, 2020
CompletedFirst Posted
Study publicly available on registry
February 11, 2020
CompletedStudy Start
First participant enrolled
June 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 23, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 23, 2021
CompletedOctober 24, 2024
October 1, 2024
11 months
February 3, 2020
October 22, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
PTSD Checklist for DSM-5 (PCL-5) Total Scores
The PCL-5 is a 17-item self-report questionnaire designed to assess PTSD symptoms among civilians. In the current study, PCL-5 total scores will be utilized. Specifically, we will examine the impact of the intervention on change in PCL-5 scores across time (i.e., from baseline to post-delivery follow-up). Scores on the PCL-5 range from 0 to 80, with higher scores indicating more symptoms.
Baseline to follow-up (follow-up will occur at one-month following the baby's birth)
Baby's Weight at Birth in Pounds/Ounces
Each baby's weight (in pounds/ounces) will be derived from the online medical record following delivery. This outcome will be used to determine the relationship between maternal PTSD symptoms (as indexed by the PCL-5 total scores--above) and infant weight at birth.
Baseline to birth of baby.
Total Gestation Length in Weeks
The total gestation length, in weeks, will be derived from the online medical record following the baby's birth. This outcome will be used to determine the relationship between maternal PTSD symptoms (as indexed by the PCL-5 total scores--above) and total weeks gestation at birth.
Baseline to birth of baby.
Baby's APGAR Score at Birth
Each baby's APGAR score will be derived from the online medical record following delivery. APGAR scores range from 0-10, with higher scores indicating better health at birth for baby. APGAR scores will be used to determine the relationship between maternal PTSD symptoms (as indexed by the PCL-5 total scores--above) and infant health at birth.
Baseline to birth of baby.
Study Arms (1)
PTSD Psychoeducation + Skills Intervention
EXPERIMENTALInterventions
A brief computer-assisted intervention (psychoeducation + skills) for pregnant women with elevated PTSD symptoms.
Eligibility Criteria
You may qualify if:
- years old
- Fluent in English
You may not qualify if:
- Active and severe domestic violence
- Evidence of a significant mental illness or current substance use disorder that would impede the completion of the intervention
- Suicidal individuals deemed at immediate danger or risk (i.e., requiring immediate hospitalization or treatment)
- Women who smoke
- Women who have a metabolic or endocrine disorder.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of South Carolina Institute of Psychiatry
Charleston, South Carolina, 29425, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 3, 2020
First Posted
February 11, 2020
Study Start
June 5, 2020
Primary Completion
April 23, 2021
Study Completion
April 23, 2021
Last Updated
October 24, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share